Skinvisible, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.005 million compared to USD 0.05998 million a year ago. Net loss was USD 1.52 million compared to USD 0.214519 million a year ago.

Basic loss per share from continuing operations was USD 0.33 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.33 compared to USD 0.05 a year ago.